Mabano, Concepcion P.
HRN: 20-30-99 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/13/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
05/13/2022
05/20/2022
IV
4.5g
Q8
Pleural Effusion Right, Prob Sec To HAP
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes